---
title: "Drugs Made In America Acquisition (DMAA.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/DMAA.US/norm.md"
symbol: "DMAA.US"
name: "Drugs Made In America Acquisition"
parent: "https://longbridge.com/zh-HK/quote/DMAA.US.md"
datetime: "2026-03-04T04:08:45.221Z"
locales:
  - [en](https://longbridge.com/en/quote/DMAA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DMAA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DMAA.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/DMAA.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/DMAA.US/norm.md)


# Drugs Made In America Acquisition (DMAA.US) — 財務報表

## 損益表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.0652 | 0.0683 | 0.0492 | -0.0327 | -0.0200 |
| ROE | -120.69% | -127.78% | -135.24% | - | 627.43% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | 2.18M | 2.29M | 1.25M | -279875.00 | -144928.00 |
| 營業利潤 | -263703.00 | -131919.00 | -330925.00 | -279875.00 | -144928.00 |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 237.63M | 235.21M | 232.81M | 550824.00 | 426139.00 |
| 權益乘數 | -32.43 | -32.89 | -32.44 | -2.25 | -2.58 |
| 每股凈資產 | -0.2186 | -0.2134 | -0.2141 | -0.0286 | -0.0192 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 717.00 | 822.00 | 923.00 | 1351.00 | 2095.00 |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | - | - | - | - | - |
| 凈債務 | -717.00 | -822.00 | 59975.00 | 660973.00 | 549920.00 |

## 現金流量表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -56108.00 | -106655.00 | -251244.00 | -123152.00 | - |
| 投資現金流 | 0.0000 | 0.0000 | -231.15M | - | - |
| 融資現金流 | 56003.00 | 106554.00 | 231.40M | 123373.00 | - |
| 自由現金流 | 11781.00 | -46287.00 | -120158.00 | - | - |
| 現金流充裕率 | - | - | -27.92% | -11.97% | - |
| 舉債與償債 | - | - | - | 1.39M | - |
| 資本支出 | - | - | - | - | - |